Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Wu, Cho Kai ^a,b   Huang, Yin Tsen ^c   Lee, Jen Kuang ^a,c,d   Chiang, Liang Ting ^a   Chiang, Fu Tien ^b,c   Huang, Shu Wei ^e   Lin, Jiunn Lee ^a   Tseng, Chuen Den ^a   Chen, Yau Hung ^f   Tsai, Chia Ti ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAMKANG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN BINDING PROTEIN C;

ADULT; ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; DNA SEQUENCE; ECHOCARDIOGRAPHY; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE MAP; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MYBPC3 GENE; PATHOGENESIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT INDICATION;

AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; ECHOCARDIOGRAPHY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HAPLOTYPES; HEART FAILURE, DIASTOLIC; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859841325     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035242     Document Type: Article

References (29)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, et al. (1997) The epidemiology of heart failure. Eur Heart J 18: 208-225.
2. Chatterjee K, Massie B, (2007) Systolic and diastolic heart failure: Differences and similarities. J Card Fail 13: 569-576.
3. Katz AM, Zile MR, (2006) New molecular mechanism in diastolic heart failure. Circulation 113: 1922-1925.
4. Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, et al. (2009) Hypophosphorylation of the stiff n2b titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104: 780-786.
5. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, et al. (2000) A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 102: 1944-1949.
6. Leszek P, Szperl M, Klisiewicz A, Janas J, Rozanski J, et al. (2008) Alterations in calcium regulatory protein expression in patients with preserved left ventricle systolic function and mitral valve stenosis. J Card Fail 14: 873-880.
7. Defer N, Azroyan A, Pecker F, Pavoine C, (2007) Tnfr1 and tnfr2 signaling interplay in cardiac myocytes. J Biol Chem 282: 35564-35573.
8. Wu CK, Luo JL, Wu XM, Tsai CT, Lin JW, et al. (2009) A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. Atherosclerosis 205: 497-502.
9. Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, et al. (2010) Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J 10: 46-53.
10. McClellan G, Kulikovskaya I, Winegrad S, (2001) Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein c. Biophys J 81: 1083-1092.
11. Pohlmann L, Kroger I, Vignier N, Schlossarek S, Kramer E, et al. (2007) Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 101: 928-938.
12. Dhandapany PS, Sadayappan S, Xue Y, Powell GT, Rani DS, et al. (2009) A common mybpc3 (cardiac myosin binding protein c) variant associated with cardiomyopathies in south asia. Nat Genet 41: 187-191.
13. Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, et al. (2010) Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol 55: 1444-1453.
14. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, et al. (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-c knockout mice. Circ Res 90: 594-601.
15. Wu CK, Tsai CT, Chang YC, Luo JL, Wang YC, et al. (2009) Genetic polymorphisms of the angiotensin ii type 1 receptor gene and diastolic heart failure. J Hypertens 27: 502-507.
16. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: Analysis and visualization of ld and haplotype maps. Bioinformatics 21: 263-265.
17. Jurinke C, van den Boom D, Cantor CR, Koster H, (2002) The use of massarray technology for high throughput genotyping. Adv Biochem Eng Biotechnol 77: 57-74.
18. Purcell S, Cherny SS, Sham PC, (2003) Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150.
19. Yip GW, Wang M, Wang T, Chan S, Fung JW, et al. (2008) The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 94: 573-580.
20. Angeja BG, Grossman W, (2003) Evaluation and management of diastolic heart failure. Circulation 107: 659-663.
21. Flashman E, Redwood C, Moolman-Smook J, Watkins H, (2004) Cardiac myosin binding protein c: Its role in physiology and disease. Circ Res 94: 1279-1289.
22. Sadayappan S, Osinska H, Klevitsky R, Lorenz JN, Sargent M, et al. (2006) Cardiac myosin binding protein c phosphorylation is cardioprotective. Proc Natl Acad Sci U S A 103: 16918-16923.
23. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, et al. (1998) Mutations in the gene for cardiac myosin-binding protein c and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338: 1248-1257.
24. Kubo T, Kitaoka H, Okawa M, Matsumura Y, Hitomi N, et al. (2005) Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein c gene among japanese. J Am Coll Cardiol 46: 1737-1743.
25. Stelzer JE, Fitzsimons DP, Moss RL, (2006) Ablation of myosin-binding protein-c accelerates force development in mouse myocardium. Biophys J 90: 4119-4127.
26. El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh YH, et al. (2007) Decreased phosphorylation levels of cardiac myosin-binding protein-c in human and experimental heart failure. J Mol Cell Cardiol 43: 223-229.
27. Kurada BR, Li LC, Mulherkar N, Subramanian M, Prasad KV, et al. (2009) A splice variant of ig20, is indispensable for mapk activation and protection against apoptosis upon tumor necrosis factor-alpha treatment. J Biol Chem 284: 13533-13541.
28. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, et al. (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92: 2303-2312.
29. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF, (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A 86: 6753-6757.